Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Imago BioSciences, Inc. - Common stock (NQ:IMGO)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 35.72 (1)
Ask (Size) 36.29 (1)
Prev. Close 36.01
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Healthcare Stocks That Will Be Big Winners in 2023
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider. 
Via InvestorPlace
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. 
Via InvestorPlace

Performance

More News

Read More
Looking Into Imago BioSciences's Recent Short Interest
Via Benzinga
5 Most Expensive Health Care Stocks You Should Worry About
Via Benzinga
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
From Merck & Co., Inc.
Via Business Wire
Analyst Ratings for Imago BioSciences
Via Benzinga
What 5 Analyst Ratings Have To Say About Imago BioSciences
Via Benzinga
Expert Ratings for Imago BioSciences
Via Benzinga
How Is The Market Feeling About Imago BioSciences?
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
From Brodsky & Smith LLC
Via GlobeNewswire
3 Dow Stocks to Take Seriously in 2023
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
Via Benzinga
IMAGO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Imago BioSciences, Inc. - IMGO
From Kahn Swick & Foti, LLC
Via Business Wire
Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday
Via Benzinga
TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune
Via AB Newswire
Topics Death Economy Stocks
Exposures COVID-19 Death Interest Rates
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Down More Than 100 Points; Gold Falls 1%
Via Benzinga
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
OPEC Rumors, Energy Stocks Drag Wall Street
Via Talk Markets
Crude Oil Down Over 5%; Imago BioSciences Shares Spike Higher
Via Benzinga
Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday
Via Benzinga
Imago BioSciences (NASDAQ: IMGO) to be Acquired by Merck (NYSE: MRK) for $1.35 Billion
Via Spotlight Growth
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
Via The Motley Fool

Frequently Asked Questions

Is Imago BioSciences, Inc. - Common stock publicly traded?
Yes, Imago BioSciences, Inc. - Common stock is publicly traded.
What exchange does Imago BioSciences, Inc. - Common stock trade on?
Imago BioSciences, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Imago BioSciences, Inc. - Common stock?
The ticker symbol for Imago BioSciences, Inc. - Common stock is IMGO on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.